- Home
- BANR vs SLNO Comparison
BANR vs SLNO Comparison
Compare BANR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANR
- SLNO
- Stock Information
- Founded
- BANR 1890
- SLNO 1999
- Country
- BANR United States
- SLNO United States
- Employees
- BANR N/A
- SLNO N/A
- Industry
- BANR Major Banks
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BANR Finance
- SLNO Health Care
- Exchange
- BANR Nasdaq
- SLNO Nasdaq
- Market Cap
- BANR 2.3B
- SLNO 2.2B
- IPO Year
- BANR 1995
- SLNO 2014
- Fundamental
- Price
- BANR $67.28
- SLNO $46.13
- Analyst Decision
- BANR Buy
- SLNO Strong Buy
- Analyst Count
- BANR 6
- SLNO 5
- Target Price
- BANR $73.80
- SLNO $71.20
- AVG Volume (30 Days)
- BANR 178.8K
- SLNO 390.6K
- Earning Date
- BANR 04-16-2025
- SLNO 03-05-2025
- Dividend Yield
- BANR 2.81%
- SLNO N/A
- EPS Growth
- BANR N/A
- SLNO N/A
- EPS
- BANR 4.88
- SLNO N/A
- Revenue
- BANR $601,023,000.00
- SLNO N/A
- Revenue This Year
- BANR N/A
- SLNO N/A
- Revenue Next Year
- BANR $6.35
- SLNO N/A
- P/E Ratio
- BANR $13.99
- SLNO N/A
- Revenue Growth
- BANR N/A
- SLNO N/A
- 52 Week Low
- BANR $42.00
- SLNO $36.61
- 52 Week High
- BANR $78.05
- SLNO $60.92
- Technical
- Relative Strength Index (RSI)
- BANR 41.02
- SLNO 40.51
- Support Level
- BANR $67.81
- SLNO $48.48
- Resistance Level
- BANR $70.06
- SLNO $52.46
- Average True Range (ATR)
- BANR 1.62
- SLNO 2.07
- MACD
- BANR -0.29
- SLNO -0.47
- Stochastic Oscillator
- BANR 4.08
- SLNO 0.94
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.